1.
Johnson W, Mishra A, Binder A, Gru A, Porcu P. Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?. Haematologica 2019; 104(5):864-867; https://doi.org/10.3324/haematol.2018.214536.